Dyne Therapeutics, Inc. (NYSE:DYN) Receives $27.20 Consensus Price Target from Analysts
Shares of Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) have been given an average rating of “Buy” by the five brokerages that are presently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year […]
More Stories
Virgin Wines UK (LON:VINO) Sets New 52-Week Low – What’s Next?
Virgin Wines UK PLC (LON:VINO – Get Free Report)’s share price hit a new 52-week low during trading on Monday...
Guild Esports (LON:GILD) Sets New 12-Month Low – Should You Sell?
Shares of Guild Esports Plc (LON:GILD – Get Free Report) reached a new 52-week low on Monday . The stock...
BIO-key International, Inc. (NASDAQ:BKYI) Short Interest Down 82.4% in November
BIO-key International, Inc. (NASDAQ:BKYI – Get Free Report) saw a large decline in short interest during the month of November....
CommScope (NASDAQ:COMM) Stock Price Up 13.7% – Still a Buy?
CommScope Holding Company, Inc. (NASDAQ:COMM – Get Free Report) rose 13.7% on Monday . The company traded as high as...
iShares Bitcoin Trust (NASDAQ:IBIT) Shares Down 4.5% – Here’s Why
Shares of iShares Bitcoin Trust (NASDAQ:IBIT – Get Free Report) fell 4.5% during trading on Monday . The company traded...
Short Interest in AOT Growth & Innovation ETF (NASDAQ:AOTG) Drops By 66.7%
AOT Growth & Innovation ETF (NASDAQ:AOTG – Get Free Report) saw a significant decline in short interest in November. As...